ruthenium has been researched along with staurosporine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, P; Meggers, E; Zhang, L | 1 |
| Bregman, H; Carroll, PJ; Meggers, E | 1 |
| Amos, A; Bregman, H; Bullock, AN; Debreczeni, JE; Knapp, S; Lee, WH; Meggers, E; Pagano, N; Russo, S; von Delft, F | 1 |
3 other study(ies) available for ruthenium and staurosporine
| Article | Year |
|---|---|
Ruthenium complexes as protein kinase inhibitors.
Topics: Carbazoles; Crystallography, X-Ray; Enzyme Inhibitors; Indoles; Inhibitory Concentration 50; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Kinase Inhibitors; Ruthenium; Staurosporine; Structure-Activity Relationship | 2004 |
Rapid access to unexplored chemical space by ligand scanning around a ruthenium center: discovery of potent and selective protein kinase inhibitors.
Topics: Carbazoles; Crystallography, X-Ray; Drug Design; Fungal Proteins; Glycogen Synthase Kinase 3; Kinetics; Ligands; Mitogen-Activated Protein Kinases; Models, Molecular; Molecular Structure; Organometallic Compounds; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Ruthenium; Staurosporine; Structure-Activity Relationship; Substrate Specificity | 2006 |
Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
Topics: Binding Sites; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Humans; Molecular Structure; Protein Conformation; Protein Isoforms; Protein Structure, Tertiary; Proto-Oncogene Proteins c-pim-1; Ruthenium; Staurosporine; Structure-Activity Relationship | 2009 |